InMed Pharmaceuticals Inc. financial data

Symbol
INM on Nasdaq
Industry
Pharmaceutical Preparations
Location
1445 885 West Georgia St., Vancouver, British Columbia, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
June 30
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 594 % +77.2%
Quick Ratio 66.2 % +18.8%
Debt-to-equity 29.6 % -7.42%
Return On Equity -91.8 % +38.7%
Return On Assets -46.2 % +59.3%
Operating Margin -148 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.3M shares +301%
Common Stock, Shares, Outstanding 667K shares -80%
Entity Public Float 2.35M USD -26.1%
Common Stock, Value, Issued 84.2M USD +8.48%
Weighted Average Number of Shares Outstanding, Basic 620K shares +273%
Weighted Average Number of Shares Outstanding, Diluted 620K shares +273%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.26M USD +40.2%
Revenue from Contract with Customer, Excluding Assessed Tax 310K USD -29.2%
Cost of Revenue 771K USD -12.4%
Research and Development Expense 771K USD -40.3%
General and Administrative Expense 1.42M USD +9.49%
Costs and Expenses -2.34M USD +37.1%
Operating Income (Loss) -6.97M USD +63.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.68M USD +33.9%
Income Tax Expense (Benefit) 6.8K USD
Net Income (Loss) Attributable to Parent -1.68M USD +33.9%
Earnings Per Share, Basic -2.71 USD/shares +82.2%
Earnings Per Share, Diluted -2.71 USD/shares +82.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.58M USD -17.1%
Cash, Cash Equivalents, and Short-term Investments 5.6M USD -17.6%
Accounts Receivable, after Allowance for Credit Loss, Current 285K USD +71.7%
Inventory, Net 1.22M USD +7.68%
Assets, Current 7.28M USD -12.2%
Property, Plant and Equipment, Net 1.34M USD +118%
Operating Lease, Right-of-Use Asset 728K USD
Intangible Assets, Net (Excluding Goodwill) 1.74M USD
Goodwill 2.02M USD
Other Assets, Noncurrent 100K USD -1.76%
Assets 10.5M USD -4.14%
Accounts Payable, Current 2K USD
Employee-related Liabilities, Current 102K USD
Accrued Liabilities, Current 85.5K USD
Liabilities, Current 1.44M USD +7.22%
Operating Lease, Liability, Noncurrent 634K USD
Liabilities 2.07M USD +54.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 129K USD 0%
Retained Earnings (Accumulated Deficit) -111M USD -6.56%
Stockholders' Equity Attributable to Parent 8.4M USD
Liabilities and Equity 10.5M USD -4.14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.83M USD +16%
Net Cash Provided by (Used in) Financing Activities 838K USD
Common Stock, Shares, Issued 667K shares -80%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.17M USD -60.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.58M USD -17.1%
Deferred Tax Assets, Valuation Allowance 22.7M USD +7.73%
Deferred Tax Assets, Gross 22.7M USD +7.73%
Operating Lease, Liability 1.06M USD +261%
Depreciation 13.6K USD -1.83%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.5M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid 1.14M USD +284%
Property, Plant and Equipment, Gross 2.37M USD +43.8%
Operating Lease, Liability, Current 424K USD +44.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 367K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 453K USD +52.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 84.1K USD +1666%
Lessee, Operating Lease, Liability, to be Paid, Year Three 219K USD -80%
Additional Paid in Capital 38.1M USD -0.74%
Amortization of Intangible Assets 41K USD 0%
Depreciation, Depletion and Amortization 54.6K USD -0.46%
Deferred Tax Assets, Net of Valuation Allowance 18.7M USD +33.7%
Share-based Payment Arrangement, Expense 29K USD +15%